HEADER TRANSFERASE 01-OCT-07 2RFN TITLE X-RAY STRUCTURE OF C-MET WITH INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1048-1351; COMPND 5 SYNONYM: HGF RECEPTOR, SCATTER FACTOR RECEPTOR, SF RECEPTOR, HGF/SF COMPND 6 RECEPTOR, MET PROTO-ONCOGENE TYROSINE KINASE, C-MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS C-MET HGF RECEPTOR TYROSINE KINSE KINASE DOMAIN, ATP-BINDING, KEYWDS 2 GLYCOPROTEIN, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHORYLATION, PROTO- KEYWDS 3 ONCOGENE, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR S.F.BELLON,P.KAPLAN-LEFKO,Y.YANG,Y.ZHANG,J.MORIGUCHI,I.DUSSAULT REVDAT 5 30-AUG-23 2RFN 1 REMARK SEQADV REVDAT 4 13-JUL-11 2RFN 1 VERSN REVDAT 3 24-FEB-09 2RFN 1 VERSN REVDAT 2 15-APR-08 2RFN 1 JRNL REVDAT 1 06-NOV-07 2RFN 0 JRNL AUTH S.F.BELLON,P.KAPLAN-LEFKO,Y.YANG,Y.ZHANG,J.MORIGUCHI,K.REX, JRNL AUTH 2 C.W.JOHNSON,P.E.ROSE,A.M.LONG,A.B.O'CONNOR,Y.GU,A.COXON, JRNL AUTH 3 T.S.KIM,A.TASKER,T.L.BURGESS,I.DUSSAULT JRNL TITL C-MET INHIBITORS WITH NOVEL BINDING MODE SHOW ACTIVITY JRNL TITL 2 AGAINST SEVERAL HEREDITARY PAPILLARY RENAL CELL JRNL TITL 3 CARCINOMA-RELATED MUTATIONS. JRNL REF J.BIOL.CHEM. V. 283 2675 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18055465 JRNL DOI 10.1074/JBC.M705774200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 24997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1305 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1747 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.3220 REMARK 3 BIN FREE R VALUE SET COUNT : 90 REMARK 3 BIN FREE R VALUE : 0.3850 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4233 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 167 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.68000 REMARK 3 B22 (A**2) : -3.39000 REMARK 3 B33 (A**2) : -1.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.487 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.320 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.278 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.292 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.925 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4440 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6027 ; 1.254 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 531 ; 5.352 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 178 ;36.518 ;23.652 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 738 ;17.748 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;17.166 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 675 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3292 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2111 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3001 ; 0.312 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 170 ; 0.154 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.195 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.096 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2749 ; 0.423 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4345 ; 0.751 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1972 ; 0.856 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1682 ; 1.369 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1057 A 1160 2 REMARK 3 1 B 1056 B 1160 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 388 ; 0.06 ; 0.05 REMARK 3 MEDIUM POSITIONAL 1 A (A): 342 ; 0.54 ; 0.50 REMARK 3 TIGHT THERMAL 1 A (A**2): 388 ; 0.20 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 342 ; 0.47 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1161 A 1351 2 REMARK 3 1 B 1161 B 1351 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 A (A): 664 ; 0.04 ; 0.05 REMARK 3 MEDIUM POSITIONAL 2 A (A): 685 ; 0.47 ; 0.50 REMARK 3 TIGHT THERMAL 2 A (A**2): 664 ; 0.05 ; 0.50 REMARK 3 MEDIUM THERMAL 2 A (A**2): 685 ; 0.33 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1058 A 1160 REMARK 3 ORIGIN FOR THE GROUP (A): 69.7117 11.1454 110.2003 REMARK 3 T TENSOR REMARK 3 T11: -0.1476 T22: -0.0646 REMARK 3 T33: -0.1572 T12: 0.0527 REMARK 3 T13: -0.0535 T23: 0.0071 REMARK 3 L TENSOR REMARK 3 L11: 2.3985 L22: 6.5452 REMARK 3 L33: 3.9458 L12: -1.3807 REMARK 3 L13: -2.4821 L23: -0.8533 REMARK 3 S TENSOR REMARK 3 S11: 0.0855 S12: 0.1778 S13: 0.0033 REMARK 3 S21: -0.5199 S22: -0.1065 S23: 0.3949 REMARK 3 S31: 0.1349 S32: -0.1403 S33: 0.0210 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1161 A 1351 REMARK 3 ORIGIN FOR THE GROUP (A): 52.0286 29.5600 119.7944 REMARK 3 T TENSOR REMARK 3 T11: -0.2326 T22: -0.1670 REMARK 3 T33: -0.1058 T12: 0.1083 REMARK 3 T13: 0.0684 T23: -0.1062 REMARK 3 L TENSOR REMARK 3 L11: 3.2974 L22: 2.8036 REMARK 3 L33: 4.0160 L12: -0.8944 REMARK 3 L13: -1.2904 L23: 1.1405 REMARK 3 S TENSOR REMARK 3 S11: 0.2957 S12: 0.1938 S13: 0.2060 REMARK 3 S21: -0.2020 S22: -0.3618 S23: 0.0707 REMARK 3 S31: -0.3879 S32: -0.3614 S33: 0.0662 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1057 B 1160 REMARK 3 ORIGIN FOR THE GROUP (A): 68.2270 28.9124 84.5873 REMARK 3 T TENSOR REMARK 3 T11: -0.0695 T22: -0.1419 REMARK 3 T33: -0.2156 T12: -0.0541 REMARK 3 T13: 0.0048 T23: 0.0193 REMARK 3 L TENSOR REMARK 3 L11: 2.2211 L22: 5.4591 REMARK 3 L33: 3.7780 L12: 0.7434 REMARK 3 L13: 1.7593 L23: -1.7349 REMARK 3 S TENSOR REMARK 3 S11: -0.0686 S12: -0.1203 S13: 0.0534 REMARK 3 S21: 0.6417 S22: 0.0073 S23: 0.1154 REMARK 3 S31: -0.1828 S32: 0.0677 S33: 0.0613 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1161 B 1351 REMARK 3 ORIGIN FOR THE GROUP (A): 50.2580 9.9672 76.3978 REMARK 3 T TENSOR REMARK 3 T11: -0.1743 T22: -0.1428 REMARK 3 T33: -0.0850 T12: -0.1232 REMARK 3 T13: -0.0882 T23: 0.0013 REMARK 3 L TENSOR REMARK 3 L11: 3.4975 L22: 2.9558 REMARK 3 L33: 4.3758 L12: 1.3435 REMARK 3 L13: 1.2237 L23: 0.6447 REMARK 3 S TENSOR REMARK 3 S11: 0.2749 S12: -0.2838 S13: -0.2078 REMARK 3 S21: 0.0779 S22: -0.1327 S23: 0.2422 REMARK 3 S31: 0.1689 S32: -0.5093 S33: -0.1423 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2RFN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044800. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 130 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24997 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1R1W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 6000, 1.0M LICL2, 0.1M SODIUM REMARK 280 CITRATE, PH 5.0, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.25450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.56400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.45950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.56400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.25450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.45950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 GLY A 1085 REMARK 465 ARG A 1086 REMARK 465 GLY A 1087 REMARK 465 HIS A 1088 REMARK 465 PHE A 1223 REMARK 465 GLY A 1224 REMARK 465 LEU A 1225 REMARK 465 ALA A 1226 REMARK 465 ARG A 1227 REMARK 465 ASP A 1228 REMARK 465 MET A 1229 REMARK 465 TYR A 1230 REMARK 465 ASP A 1231 REMARK 465 LYS A 1232 REMARK 465 GLU A 1233 REMARK 465 TYR A 1234 REMARK 465 TYR A 1235 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 LYS A 1244 REMARK 465 LEU A 1245 REMARK 465 HIS A 1352 REMARK 465 HIS A 1353 REMARK 465 HIS A 1354 REMARK 465 HIS A 1355 REMARK 465 HIS A 1356 REMARK 465 MET B 1047 REMARK 465 GLN B 1048 REMARK 465 ASN B 1049 REMARK 465 THR B 1050 REMARK 465 VAL B 1051 REMARK 465 HIS B 1052 REMARK 465 ILE B 1053 REMARK 465 ASP B 1054 REMARK 465 LEU B 1055 REMARK 465 GLY B 1085 REMARK 465 ARG B 1086 REMARK 465 GLY B 1087 REMARK 465 HIS B 1088 REMARK 465 PHE B 1223 REMARK 465 GLY B 1224 REMARK 465 LEU B 1225 REMARK 465 ALA B 1226 REMARK 465 ARG B 1227 REMARK 465 ASP B 1228 REMARK 465 MET B 1229 REMARK 465 TYR B 1230 REMARK 465 ASP B 1231 REMARK 465 LYS B 1232 REMARK 465 GLU B 1233 REMARK 465 TYR B 1234 REMARK 465 TYR B 1235 REMARK 465 SER B 1236 REMARK 465 VAL B 1237 REMARK 465 HIS B 1238 REMARK 465 ASN B 1239 REMARK 465 LYS B 1240 REMARK 465 THR B 1241 REMARK 465 GLY B 1242 REMARK 465 ALA B 1243 REMARK 465 LYS B 1244 REMARK 465 LEU B 1245 REMARK 465 HIS B 1352 REMARK 465 HIS B 1353 REMARK 465 HIS B 1354 REMARK 465 HIS B 1355 REMARK 465 HIS B 1356 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CG CD OE1 NE2 REMARK 470 ARG A1114 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1150 CG CD OE1 OE2 REMARK 470 LYS A1259 CG CD CE NZ REMARK 470 HIS A1351 CG ND1 CD2 CE1 NE2 REMARK 470 ASN B1100 CG OD1 ND2 REMARK 470 ASP B1101 CG OD1 OD2 REMARK 470 ARG B1114 CG CD NE CZ NH1 NH2 REMARK 470 GLU B1150 CG CD OE1 OE2 REMARK 470 LYS B1199 CG CD CE NZ REMARK 470 LYS B1259 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A1116 -74.07 -152.42 REMARK 500 ARG A1203 -29.19 73.65 REMARK 500 GLN A1258 36.76 39.51 REMARK 500 THR B1116 -68.54 -152.67 REMARK 500 ARG B1203 -30.03 74.29 REMARK 500 GLN B1258 40.81 32.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 1089 GLY A 1090 -35.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AM7 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AM7 B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RFS RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF SU11274 BOUND TO C-MET DBREF 2RFN A 1048 1351 UNP P08581 MET_HUMAN 1048 1351 DBREF 2RFN B 1048 1351 UNP P08581 MET_HUMAN 1048 1351 SEQADV 2RFN MET A 1047 UNP P08581 INITIATING METHIONINE SEQADV 2RFN LEU A 1272 UNP P08581 VAL 1272 CONFLICT SEQADV 2RFN HIS A 1352 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS A 1353 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS A 1354 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS A 1355 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS A 1356 UNP P08581 EXPRESSION TAG SEQADV 2RFN MET B 1047 UNP P08581 INITIATING METHIONINE SEQADV 2RFN LEU B 1272 UNP P08581 VAL 1272 CONFLICT SEQADV 2RFN HIS B 1352 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS B 1353 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS B 1354 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS B 1355 UNP P08581 EXPRESSION TAG SEQADV 2RFN HIS B 1356 UNP P08581 EXPRESSION TAG SEQRES 1 A 310 MET GLN ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN SEQRES 2 A 310 PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY SEQRES 3 A 310 PRO SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY SEQRES 4 A 310 ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU SEQRES 5 A 310 ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER SEQRES 6 A 310 LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE SEQRES 7 A 310 LEU THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO SEQRES 8 A 310 ASN VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU SEQRES 9 A 310 GLY SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY SEQRES 10 A 310 ASP LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO SEQRES 11 A 310 THR VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA SEQRES 12 A 310 LYS GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS SEQRES 13 A 310 ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS SEQRES 14 A 310 PHE THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP SEQRES 15 A 310 MET TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR SEQRES 16 A 310 GLY ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER SEQRES 17 A 310 LEU GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SEQRES 18 A 310 SER PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY SEQRES 19 A 310 ALA PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR SEQRES 20 A 310 VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU SEQRES 21 A 310 TYR CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS SEQRES 22 A 310 TRP HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU SEQRES 23 A 310 LEU VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE SEQRES 24 A 310 GLY GLU HIS TYR VAL HIS HIS HIS HIS HIS HIS SEQRES 1 B 310 MET GLN ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN SEQRES 2 B 310 PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY SEQRES 3 B 310 PRO SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY SEQRES 4 B 310 ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU SEQRES 5 B 310 ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER SEQRES 6 B 310 LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE SEQRES 7 B 310 LEU THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO SEQRES 8 B 310 ASN VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU SEQRES 9 B 310 GLY SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY SEQRES 10 B 310 ASP LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO SEQRES 11 B 310 THR VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA SEQRES 12 B 310 LYS GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS SEQRES 13 B 310 ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS SEQRES 14 B 310 PHE THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP SEQRES 15 B 310 MET TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR SEQRES 16 B 310 GLY ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER SEQRES 17 B 310 LEU GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SEQRES 18 B 310 SER PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY SEQRES 19 B 310 ALA PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR SEQRES 20 B 310 VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU SEQRES 21 B 310 TYR CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS SEQRES 22 B 310 TRP HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU SEQRES 23 B 310 LEU VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE SEQRES 24 B 310 GLY GLU HIS TYR VAL HIS HIS HIS HIS HIS HIS HET AM7 A 1 45 HET AM7 B 1 45 HETNAM AM7 2-BENZYL-5-(3-FLUORO-4-{[6-METHOXY-7-(3-MORPHOLIN-4- HETNAM 2 AM7 YLPROPOXY)QUINOLIN-4-YL]OXY}PHENYL)-3-METHYLPYRIMIDIN- HETNAM 3 AM7 4(3H)-ONE FORMUL 3 AM7 2(C35 H35 F N4 O5) FORMUL 5 HOH *167(H2 O) HELIX 1 1 ASN A 1059 GLN A 1067 1 9 HELIX 2 2 HIS A 1068 VAL A 1070 5 3 HELIX 3 3 GLY A 1072 SER A 1074 5 3 HELIX 4 4 ASP A 1117 PHE A 1134 1 18 HELIX 5 5 ASP A 1164 ASN A 1171 1 8 HELIX 6 6 THR A 1177 LYS A 1198 1 22 HELIX 7 7 ALA A 1206 ARG A 1208 5 3 HELIX 8 8 PRO A 1246 MET A 1250 5 5 HELIX 9 9 ALA A 1251 GLN A 1258 1 8 HELIX 10 10 THR A 1261 THR A 1278 1 18 HELIX 11 11 ASP A 1291 GLN A 1298 1 8 HELIX 12 12 PRO A 1309 TRP A 1320 1 12 HELIX 13 13 LYS A 1323 ARG A 1327 5 5 HELIX 14 14 SER A 1329 PHE A 1344 1 16 HELIX 15 15 ASN B 1059 GLN B 1067 1 9 HELIX 16 16 GLY B 1072 SER B 1074 5 3 HELIX 17 17 ASP B 1117 PHE B 1134 1 18 HELIX 18 18 ASP B 1164 ASN B 1171 1 8 HELIX 19 19 THR B 1177 LYS B 1198 1 22 HELIX 20 20 ALA B 1206 ARG B 1208 5 3 HELIX 21 21 PRO B 1246 MET B 1250 5 5 HELIX 22 22 ALA B 1251 GLN B 1258 1 8 HELIX 23 23 THR B 1261 THR B 1278 1 18 HELIX 24 24 ASP B 1291 GLN B 1298 1 8 HELIX 25 25 PRO B 1309 TRP B 1320 1 12 HELIX 26 26 LYS B 1323 ARG B 1327 5 5 HELIX 27 27 SER B 1329 THR B 1343 1 15 SHEET 1 A 5 LEU A1076 VAL A1083 0 SHEET 2 A 5 VAL A1092 LEU A1098 -1 O HIS A1094 N HIS A1079 SHEET 3 A 5 LYS A1104 SER A1111 -1 O VAL A1109 N TYR A1093 SHEET 4 A 5 LEU A1154 PRO A1158 -1 O VAL A1155 N LYS A1110 SHEET 5 A 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 C 5 LEU B1076 VAL B1083 0 SHEET 2 C 5 VAL B1092 LEU B1098 -1 O HIS B1094 N HIS B1079 SHEET 3 C 5 LYS B1104 SER B1111 -1 O VAL B1109 N TYR B1093 SHEET 4 C 5 LEU B1154 PRO B1158 -1 O VAL B1155 N LYS B1110 SHEET 5 C 5 GLY B1144 CYS B1146 -1 N GLY B1144 O VAL B1156 SHEET 1 D 2 CYS B1210 LEU B1212 0 SHEET 2 D 2 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 SITE 1 AC1 18 ILE A1084 PHE A1089 VAL A1092 ALA A1108 SITE 2 AC1 18 LYS A1110 PHE A1124 GLU A1127 GLY A1128 SITE 3 AC1 18 MET A1131 LEU A1140 LEU A1142 LEU A1157 SITE 4 AC1 18 PRO A1158 TYR A1159 MET A1160 LYS A1161 SITE 5 AC1 18 GLY A1163 MET A1211 SITE 1 AC2 17 ILE B1084 PHE B1089 VAL B1092 ALA B1108 SITE 2 AC2 17 LYS B1110 PHE B1124 GLU B1127 MET B1131 SITE 3 AC2 17 LEU B1142 ILE B1145 LEU B1157 PRO B1158 SITE 4 AC2 17 TYR B1159 MET B1160 LYS B1161 GLY B1163 SITE 5 AC2 17 MET B1211 CRYST1 74.509 78.919 129.128 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013421 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012671 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007744 0.00000